Clinical Outcome and Safety of Triweekly Modified FOLFIRINOX Therapy in Patients with Advanced Pancreatic Cancer [0.03%]
三周一次的改良FOLFIRINOX方案治疗晚期胰腺癌的临床疗效及安全性评估研究
Kana Hosokawa,Kenji Ikezawa,Yugo Kai et al.
Kana Hosokawa et al.
Purpose: Modified FOLFIRINOX (mFFX) therapy is widely used as first- or second-line treatment for advanced pancreatic cancer. However, adverse effects (AEs), such as cytopenia, often prevent the intended biweekly administ...
Medullary Carcinoma of the Colon: Not as Favourable as Previously Thought? [0.03%]
降结肠髓样癌的预后并不如想象中乐观？
Daniel Netto,Mugtaba Dafalla,Karim Muhammad et al.
Daniel Netto et al.
Introduction: Medullary carcinoma of the colon (MCC) is a rare, evolving subtype of colorectal cancer that is histologically and clinically distinct from poorly differentiated and undifferentiated adenocarcinoma. Comprehe...
Gallbladder Squamous Cell Carcinoma with Diffuse β-hCG Expression: A Case Report and Review of the Literature [0.03%]
弥漫性β-hCG表达的胆囊鳞状细胞癌一例报道及文献复习
Shengliang He,Dustin E Bosch,Alan Hemming
Shengliang He
Purpose: Gallbladder squamous cell carcinoma (SCC) is a rare subtype of gallbladder malignancy, comprising only 1-4% of cases. Ectopic expression of β-human chorionic gonadotropin (β-hCG) has been described in various e...
Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Colorectal Cancer Survival: A Multicenter Retrospective Cohort Study [0.03%]
C反应蛋白-白蛋白-淋巴细胞指数对结直肠癌患者生存预后的预测价值：一项多中心回顾性队列研究
Mansour Bahardoust,Mohammadsadra Shamohammadi,Negin Danesh et al.
Mansour Bahardoust et al.
Background: Colorectal cancer (CRC) has become one of the major health burdens in the world with high mortality rates, especially at the advanced stages. The C-reactive protein (CRP)-albumin-lymphocyte (CALLY) index is a ...
Multicenter Study
Journal of gastrointestinal cancer. 2025 Sep 5;56(1):183. DOI:10.1007/s12029-025-01307-8 2025
Population-Based Analysis of the Interplay between Rurality and Race in Gastric Adenocarcinoma Survival [0.03%]
基于人群的分析农村地区与种族在胃腺癌生存率中的相互作用
Nicole M Hwang,Matthew E B Dixon
Nicole M Hwang
Purpose: Despite growing efforts to understand how rurality impacts cancer outcomes, significant gaps remain in understanding its prognostic influence and its interaction with race in patients with gastric adenocarcinoma ...
Predictive Value of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve for Survival in Patients with Esophageal Cancer Following Esophagectomy [0.03%]
食管癌术后冠状动脉CT血管造影衍生的血流储备分数对生存价值的预测作用
Xiaoqin Chen,Xiongmu Tan,Yushang Yang et al.
Xiaoqin Chen et al.
Objective: This study aimed to assess the predictive value of CT-FFR on survival in patients with esophageal carcinoma (EC) after esophagectomy. Methods: ...
Safety and Efficacy of Gastric Endoscopic Submucosal Dissection in a Non-academic Western Center [0.03%]
西方非学术医疗中心胃镜下黏膜下剥离术的安全性和有效性研究
Sebastian Stefanovic,Rajko Knezevic,Maja Denkovski et al.
Sebastian Stefanovic et al.
Purpose: Endoscopic submucosal dissection (ESD) is a minimally invasive technique used to treat gastrointestinal neoplasms. Lower incidence of gastric lesions results in fewer studies of gastric ESD in the West. We aimed ...
Primary Intrahepatic Biliary Neuroendocrine Neoplasms: A Case Report and Literature Review [0.03%]
原发肝胆管神经内分泌肿瘤一例并文献复习
Zhengfu Chen,Lifu Hu,Zixian Guo et al.
Zhengfu Chen et al.
Introduction: Intrahepatic biliary neuroendocrine neoplasms (NENs) are rare neoplasms originating from neuroendocrine cells in the intrahepatic bile ducts. Patients often present without hormone-related symptoms but are a...
Global Epidemiology of PD-L1 Expression in Epstein-Barr Virus-Associated Gastric Cancer: A Systematic Review and Meta-Analysis [0.03%]
PD-L1在EB病毒阳性胃癌中的表达流行病学特征：系统评价和Meta分析
Francisco Cezar Aquino de Moraes,Gustavo Tadeu Freitas Uchôa Matheus,Luis Eduardo Rodrigues Sobreira et al.
Francisco Cezar Aquino de Moraes et al.
Background: Epstein-Barr virus-associated gastric cancer (EBVaGC) accounts for ~ 10% of gastric cancers (GC). Programmed death-ligand 1 (PD-L1) expression plays a key role in immune evasion and response to immunotherapy, ...